NNNN
Anbio Biotechnology
NASDAQ · Healthcare · Medical - Instruments & Supplies · DE
$5.25
−6.25%Margins
Gross margin
87.2%
EBITDA margin
66.7%
EBIT margin
66.7%
Net margin
74.1%
FCF margin
-77.9%
21.2%
Return on equity
21.2%
Return on assets
19.1%
Return on invested capital
0.29x
Asset turnover
-$6.7M
Cash from operations
$0.27
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025